Supply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
Another drugmaker, Eli Lilly, has said it expects tight supplies until year's end for its diabetes treatment Mounjaro, which also is prescribed for weight loss.
“It’s usually patients who are a little bit more privileged, able to take off from work to go make those drives,” Thiara said. While patients have had to deal with shortages of many medications in the past year, those taking weight-loss drugs can face coverage complications too. Employers and insurers that do pay for the weight-loss treatments often require patients to get pre-approval or to first try other strategies like diet and exercise.
Malaysia Latest News, Malaysia Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Oil prices extend rally on China stimulus cheer, tight supply outlook By Investing.comOil prices extend rally on China stimulus cheer, tight supply outlook
Read more »
| ETH Supply Down One Year Post-Merge, With Host Noelle AchesonNoelle Acheson, author of the Crypto Is Macro Now newsletter, discusses Ethereum one year post-Merge, bitcoin mining, institutional interest and more.
Read more »
Blue Diamond Invests In SAP To Improve Their Supply ChainFor Blue Diamond, bringing together demand and supply planning with real-time logistics visibility led to benefits bigger than any one solution could have provided.
Read more »
Supply problems and insurance issues make popular weight-loss drugs hard to getSupply problems and insurance complications have made it difficult for many patients to start and stay on new prescription medications used to treat obesity.
Read more »
Supply, insurance issues make weight-loss drugs hard to getSupply problems and insurance complications have made it difficult for people to start — and stay on — Wegovy and similar medications that are transforming obesity treatment, according to doctors and patients around the country. They say getting the high-demand, injectable drugs requires persistence and a fair amount of luck.
Read more »
WTI surges to the fresh YTD high above the $90.10 mark amid tighter supply expectationsWestern Texas Intermediate (WTI), the US crude oil benchmark, is trading around $90.10 so far on Friday. WTI prices climb to the Year-To-Date (YTD) hi
Read more »